| Isotretinoin | Approved Investigational | AKAP11 | 11215 |
upregulated | Isotretinoin results in increased expression of AKAP11 mRNA | 13q14.11 | |
| Isotretinoin | Approved Investigational | AKR1A1 | 10327 |
downregulated | Isotretinoin results in decreased expression of AKR1A1 mRNA | 1p34.1 | |
| Isotretinoin | Approved Investigational | ALAS1 | 211 |
downregulated | Isotretinoin results in decreased expression of ALAS1 mRNA | 3p21.2 | |
| Isotretinoin | Approved Investigational | ALCAM | 214 |
downregulated | Isotretinoin results in decreased expression of ALCAM mRNA | 3q13.11 | |
| Isotretinoin | Approved Investigational | ALDH3B2 | 222 |
downregulated | Isotretinoin results in decreased expression of ALDH3B2 mRNA | 11q13.2 | |
| Isotretinoin | Approved Investigational | ALG13 | 79868 |
downregulated | Isotretinoin results in decreased expression of ALG13 mRNA | Xq23 | |
| Isotretinoin | Approved Investigational | ALOX15B | 247 |
downregulated | Isotretinoin results in decreased expression of ALOX15B mRNA | 17p13.1 | |
| Isotretinoin | Approved Investigational | AMACR | 23600 |
downregulated | Isotretinoin results in decreased expression of AMACR mRNA | 5p13.2 | |
| Isotretinoin | Approved Investigational | ANK2 | 287 |
upregulated | Isotretinoin results in increased expression of ANK2 mRNA | 4q25-q26 | |
| Isotretinoin | Approved Investigational | ANKHD1 | 54882 |
downregulated | Isotretinoin results in decreased expression of ANKHD1 mRNA | 5q31.3 | |
| Isotretinoin | Approved Investigational | ANO10 | 55129 |
downregulated | Isotretinoin results in decreased expression of ANO10 mRNA | 3p22.1-p21.33 | |
| Isotretinoin | Approved Investigational | AP2B1 | 163 |
upregulated | Isotretinoin results in increased expression of AP2B1 mRNA | 17q12 | |
| Isotretinoin | Approved Investigational | AP3S2 | 10239 |
downregulated | Isotretinoin results in decreased expression of AP3S2 mRNA | 15q26.1 | |
| Isotretinoin | Approved Investigational | APOC1 | 341 |
downregulated | Isotretinoin results in decreased expression of APOC1 mRNA | 19q13.32 | |
| Isotretinoin | Approved Investigational | APOOL | 139322 |
downregulated | Isotretinoin results in decreased expression of APOOL mRNA | Xq21.1 | |
| Isotretinoin | Approved Investigational | ARF1P1 | 442334 |
downregulated | Isotretinoin results in decreased expression of ARF1P1 mRNA | 7q21.3 | |
| Isotretinoin | Approved Investigational | ARG2 | 384 |
downregulated | Isotretinoin results in decreased expression of ARG2 mRNA | 14q24.1 | |
| Isotretinoin | Approved Investigational | ARHGDIB | 397 |
upregulated | Isotretinoin results in increased expression of ARHGDIB mRNA | 12p12.3 | |
| Isotretinoin | Approved Investigational | ARHGEF6 | 9459 |
upregulated | Isotretinoin results in increased expression of ARHGEF6 mRNA | Xq26.3 | |
| Isotretinoin | Approved Investigational | ASAP3 | 55616 |
upregulated | Isotretinoin results in increased expression of ASAP3 mRNA | 1p36.12 | |
| Isotretinoin | Approved Investigational | ATG4A | 115201 |
downregulated | Isotretinoin results in decreased expression of ATG4A mRNA | Xq22.3 | |
| Isotretinoin | Approved Investigational | ATP2B4 | 493 |
upregulated | Isotretinoin results in increased expression of ATP2B4 mRNA | 1q32.1 | |
| Isotretinoin | Approved Investigational | ATP5C1 | 509 |
downregulated | Isotretinoin results in decreased expression of ATP5C1 mRNA | 10p14 | |
| Isotretinoin | Approved Investigational | ATP5G3 | 518 |
downregulated | Isotretinoin results in decreased expression of ATP5G3 mRNA | 2q31.1 | |
| Isotretinoin | Approved Investigational | ATP5J2 | 9551 |
downregulated | Isotretinoin results in decreased expression of ATP5J2 mRNA | 7q22.1 | |